(c) 2024 PillSync.com

venlafaxine hydrochloride capsule extended release 37.5 mg

1 INDICATIONS AND USAGE Venlafaxine hydrochloride extended-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of: • major depressive disorder (MDD) • Generalized Anxiety Disorder (GAD) • Social Anxiety Disorder (SAD) • Panic Disorder (PD) 1.1 major depressive disorder Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder (MDD). Efficacy was established in three short-term (4, 8, and 12 weeks) and two long-term, maintenance trials. 1.2 Generalized Anxiety Disorder Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of Generalized Anxiety Disorder (GAD). Efficacy was established in two 8-week and two 26-week placebo-controlled trials. 1.3 Social Anxiety Disorder Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of Social Anxiety Disorder (SAD), also known as social phobia. Efficacy was established in four 12-week and one 26-week, placebo-controlled trials. 1.4 Panic Disorder Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of Panic Disorder (PD), with or without agoraphobia. Efficacy was established in two 12-week placebo-controlled trials.

camber pharmaceuticals, inc.


3 years ago CAPSULE GREY V 9 venlafaxine hydrochloride capsule extended release 37.5 mg

CAPSULE GREY V 9

16 HOW SUPPLIED/STORAGE AND HANDLING

VENLAFAXINE HYDROCHLORIDE extended-release capsules USP are available as follows:

VENLAFAXINE HYDROCHLORIDE extended-release capsules USP, 37.5 mg are white to off white colored, round to oval shaped pellets filled in size '3' hard Gelatin capsules with grey opaque cap imprinted with 'V' in black color, white opaque body imprinted with '9' in black color. Bottle of 30 capsules NDC 31722-002-30 Bottle of 90 capsules NDC 31722-002-90 Bottle of 500 capsules NDC 31722-002-05 Carton of 100 (10 x 10) unit-dose capsules (Alu-Blister pack) NDC 31722-002-01

VENLAFAXINE HYDROCHLORIDE extended-release capsules USP, 75 mg are white to off white colored, round to oval shaped pellets filled in size '1' hard Gelatin capsules with peach opaque cap imprinted with 'V' in black color, white opaque body imprinted with '10' in black color. Bottle of 30 capsules NDC 31722-003-30 Bottle of 90 capsules NDC 31722-003-90 Bottle of 500 capsules NDC 31722-003-05 Carton of 100 (10 x 10) unit-dose capsules (Alu-Blister pack) NDC 31722-003-01

VENLAFAXINE HYDROCHLORIDE extended-release capsules USP, 150 mg are white to off white colored, round to oval shaped pellets filled in size '0' hard Gelatin capsules with orange opaque cap imprinted with 'V' in black color, white opaque body imprinted with '11' in black color. Bottle of 30 capsules NDC 31722-004-30 Bottle of 90 capsules NDC 31722-004-90 Bottle of 500 capsules NDC 31722-004-05 Carton of 100 (10 x 10) unit-dose capsules (Alu-Blister pack) NDC 31722-004-01 Store at controlled room temperature, 20° to 25°C (68° to 77°F). [see USP Controlled Room Temperature]


More pills like CAPSULE V 9

Related Pills

oxycodone hydrochloride capsule

glenmark pharmaceuticals, inc

carbidopa and levodopa tablet

american health packaging

carbidopa 25 mg levodopa 100 mg

Teva Pharmaceuticals USA, Inc.

carbidopa 25 mg levodopa 250 mg

Teva Pharmaceuticals USA, Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site